New cancer clinical trial: Vinorelbine in Advanced BRAF-like Colon Cancer

Published on: March 29, 2018 at 12:00PM
Condition:   Colon Cancer
Intervention:   Drug: Vinorelbine Tartrate
Sponsors:   The Netherlands Cancer Institute;   Vall d'Hebron Institute of Oncology;   Agendia;   European Organisation for Research and Treatment of Cancer - EORTC;   Azienda Ospedaliera Niguarda Cà Granda;   Fundación para la Investigación del Hospital Clínico de Valencia;   University of Campania "Luigi Vanvitelli";   University of Turin, Italy;   Eli Lilly and Company;   Catalan Institute of Health;   Universitaire Ziekenhuizen Leuven
Recruiting
https://ift.tt/2JaXORZ